Pelage Pharmaceuticals (Series B)
Funding Details
Awarder
Inbox
Date Award
October 15, 2025
Vertical
Regenerative Medicine
Funding Amount
$120,000,000
Company Info
Founders
Daniel Gil
Market
Hair Loss Treatments
Location
Los Angeles, CA, USA
Coinvestors
ARCH Venture Partners, GV, Main Street Advisors, Visionary Ventures Fund, YK Bioventures
Company Description

Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing first-in-class treatments for hair loss. With a focus on stem cell biology and metabolism, Pelage is advancing a new class of treatments designed to reactivate dormant hair follicle stem cells and restore the body's ability to naturally grow hair.

Links